Medication Review in Women With Depression and Anxiety

Applied Science Private University73 enrolled

Overview

This study sought to assess the impact of the MMR service on identifying and resolving TRPs, improving adherence, depression and anxiety scores in females diagnosed with depression and anxiety in Jordan

Participants were recruited into this single-blind parallel randomized controlled trial and randomized into active and control groups. A clinical pharmacist identified TRPs for all participants. Adherence, depression and anxiety scores were assessed. Active group patients received the MMR service: pharmacist-delivered counseling and a letter with recommended changes in the patient's treatment plan was sent to the patient's psychiatrist to be applied. Control group participants did not receive the intervention. Follow-up assessments were completed for all patients at 3 months from baseline. Main outcome measures were TRPs, adherence, depression and anxiety scores.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Depression, Anxiety Adherence, Patient

Interventions

Medication management reviewOTHER

The researcher screened each completed an MMR template and verified that all information in each patient template was complete. A classification system was then used to identify the TRPs which either actually or potentially interfered with the clinical outcomes for each patient.\[19\] This system was explained in detail and applied successfully in many previous studies.\[10, 14, 20\] The researcher then identified TRPs for each patient in both groups using evidence-based medicine. The TRPs including unneeded drug treatment, untreated condition/s, efficacy/effectiveness issues, safety issues, inadequate knowledge, inappropriate adherence to pharmacological therapy, inappropriate adherence to self-care activities and miscellaneous problems.

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Jordanian females or residents in Jordan for the last 12 months and planning to stay in Jordan for 6 months (the study follow-up period), * above the age of 18 years * diagnosed with depression and/or anxiety for at least 4 weeks duration * taking medications for depression and/or anxiety Exclusion Criteria: * presence of a cognitive problem or sensory impairment which may prevent communication with the patient (reported by the patient's psychiatrist) * being not able to speak or write Arabic (reported by the patient)

Outcomes

Primary Outcomes

Evaluate the effect of the medication management review service delivered to females living in Jordan and diagnosed with depression and anxiety

the medication management review service will be measured by the reduction of treatment related number after providing the service

Time frame: 6 months

Secondary Outcomes

Patient's satisfaction with the medication management review service

satisfaction will be measured by the willingness of patients to pay for the provided services

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.